These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 9654650)

  • 21. Development of (p-O-sulfamoyl)-N-alkanoyl-phenylalkyl amines as non-steroidal estrone sulfatase inhibitors.
    Kolli A; Chu GH; Rhodes ME; Inoue K; Selcer KW; Li PK
    J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):31-40. PubMed ID: 10215035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of placental estrone sulfatase activity and MCF-7 breast cancer cell proliferation by estrone-3-amino derivatives.
    Selcer KW; Jagannathan S; Rhodes ME; Li PK
    J Steroid Biochem Mol Biol; 1996 Sep; 59(1):83-91. PubMed ID: 9009241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and sulfatase inhibitory activities of non-steroidal estrone sulfatase inhibitors.
    Li PK; Milano S; Kluth L; Rhodes ME
    J Steroid Biochem Mol Biol; 1996 Sep; 59(1):41-8. PubMed ID: 9009236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogenicity, antiestrogenicity and estrone sulfatase inhibition of estrone-3-amine and estrone-3-thiol.
    Selcer KW; Li PK
    J Steroid Biochem Mol Biol; 1995 Mar; 52(3):281-6. PubMed ID: 7696150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of potent non-estrogenic estrone sulfatase inhibitors.
    Li PK; Chu GH; Guo JP; Peters A; Selcer KW
    Steroids; 1998; 63(7-8):425-32. PubMed ID: 9654650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of estrone sulfatase and its inhibitors--an important new target against hormone dependent breast cancer.
    Ahmed S; Owen CP; James K; Sampson L; Patel CK
    Curr Med Chem; 2002 Jan; 9(2):263-73. PubMed ID: 11860358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen O-sulfamates and their analogues: Clinical steroid sulfatase inhibitors with broad potential.
    Thomas MP; Potter BV
    J Steroid Biochem Mol Biol; 2015 Sep; 153():160-9. PubMed ID: 25843211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent data on estrogen sulfatases and sulfotransferases activities in human breast cancer.
    Pasqualini JR; Schatz B; Varin C; Nguyen BL
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):323-9. PubMed ID: 1580921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways.
    Santen RJ; Leszczynski D; Tilson-Mallet N; Feil PD; Wright C; Manni A; Santner SJ
    Ann N Y Acad Sci; 1986; 464():126-37. PubMed ID: 3524346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sulfatase inhibitors for recidivist breast cancer treatment: A chemical review.
    Shah R; Singh J; Singh D; Jaggi AS; Singh N
    Eur J Med Chem; 2016 May; 114():170-90. PubMed ID: 26974384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
    Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sulfamates and their therapeutic potential.
    Winum JY; Scozzafava A; Montero JL; Supuran CT
    Med Res Rev; 2005 Mar; 25(2):186-228. PubMed ID: 15478125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrone sulfatase and its inhibitors.
    Aidoo-Gyamfi K; Cartledge T; Shah K; Ahmed S
    Anticancer Agents Med Chem; 2009 Jul; 9(6):599-612. PubMed ID: 19601744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The selective estrogen enzyme modulators in breast cancer: a review.
    Pasqualini JR
    Biochim Biophys Acta; 2004 Jun; 1654(2):123-43. PubMed ID: 15172700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Steroid sulfatase: molecular biology, regulation, and inhibition.
    Reed MJ; Purohit A; Woo LW; Newman SP; Potter BV
    Endocr Rev; 2005 Apr; 26(2):171-202. PubMed ID: 15561802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Steroid sulfatase inhibitor].
    Nakata T; Ishida H; Shiotsu Y
    Nihon Rinsho; 2010 Jun; 68(6):1073-8. PubMed ID: 20535958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of estrogen sulfates in breast cancer.
    Pasqualini JR; Gelly C; Nguyen BL; Vella C
    J Steroid Biochem; 1989; 34(1-6):155-63. PubMed ID: 2560511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steroid sulfatase inhibitors: their potential in the therapy of breast cancer.
    Nussbaumer P; Billich A
    Curr Med Chem Anticancer Agents; 2005 Sep; 5(5):507-28. PubMed ID: 16178776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent developments of steroid sulfatase inhibitors as anti-cancer agents.
    Foster PA; Reed MJ; Purohit A
    Anticancer Agents Med Chem; 2008 Oct; 8(7):732-8. PubMed ID: 18855575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.